Exactech Inc (EXAC) 27.90 $EXAC 39.8% Return Seen to

New Post Public Reply Private Reply Replies (0) Message Board

Sep 2, 2016 at 7:05 PM

Exactech Inc (EXAC) 27.90 $EXAC

39.8% Return Seen to Date on SmarTrend Exactech Call (EXAC)
Comtex SmarTrend(R) - Mon Aug 29, 1:01PM CDT
SmarTrend identified an Uptrend for Exactech (NASDAQ:EXAC) on April 1st, 2016 at $20.01. In approximately 5 months, Exactech has returned 39.78% as of today's recent price of $27.97.
EXAC: 27.90 (+0.10)

Exactech Up 41.2% Since SmarTrend Uptrend Call (EXAC)
Comtex SmarTrend(R) - Fri Aug 12, 12:31AM CDT
SmarTrend identified an Uptrend for Exactech (NASDAQ:EXAC) on April 1st, 2016 at $20.01. In approximately 4 months, Exactech has returned 41.18% as of today's recent price of $28.25.
EXAC: 27.90 (+0.10)

Exactech Up 36.0% Since SmarTrend Uptrend Call (EXAC)
Comtex SmarTrend(R) - Thu Aug 04, 1:02PM CDT
SmarTrend identified an Uptrend for Exactech (NASDAQ:EXAC) on April 1st, 2016 at $20.01. In approximately 4 months, Exactech has returned 36.03% as of today's recent price of $27.22.
EXAC: 27.90 (+0.10)

Exactech (EXAC) Beats Earnings on Higher Revenues in Q2
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 10:25AM CDT
Exactech Inc. announced adjusted earnings of 31 cents per share in the second quarter of 2016.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), EXAC: 27.90 (+0.10), MLAB: 112.17 (-1.21)

Exactech Q2 Revenue Up 8% to $66.1 Million; Net Income up 20% to $4.4 Million; Diluted EPS $0.31 vs. $0.26
BusinessWire - Mon Aug 01, 3:05PM CDT
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, today announced revenue of $66.1 million for the second quarter of 2016, an 8% increase from $61.5 million in the second quarter of 2015. On a constant currency basis, revenue was up 7%. Net income increased 20% to $4.4 million, or $0.31 per diluted share, compared to $3.7 million, or $0.26 per diluted share, in the same quarter a year ago.
EXAC: 27.90 (+0.10)

Medical Instrument Q2 Earnings on Aug 1: AVGR, EXAC, GKOS
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 8:57AM CDT
Let's take a look at the major Medical Instrument stocks slated to release their quarterly reports on Aug 1.
AVGR: 4.24 (+0.03), GKOS: 30.69 (+0.62), EXAC: 27.90 (+0.10)

Exactech Shares Up 34.5% Since SmarTrend's Buy Recommendation (EXAC)
Comtex SmarTrend(R) - Thu Jul 28, 12:41AM CDT
SmarTrend identified an Uptrend for Exactech (NASDAQ:EXAC) on April 1st, 2016 at $20.01. In approximately 4 months, Exactech has returned 34.53% as of today's recent price of $26.92.
EXAC: 27.90 (+0.10)

Exactech Expands Competency in 3-D Printing with Purchase of Arcam Q10plus Systems
BusinessWire - Thu Jun 16, 8:00AM CDT
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic materials for extremities, knee, hip and spine, has confirmed the purchase of two Arcam Q10plus machines this week to expand its in-house manufacturing capabilities. This investment will advance Exactech's long-term commitment to additive manufacturing technology, also known as 3-D printing.
EXAC: 27.90 (+0.10)

Exactech (EXAC) Scales a 52-Week High on Solid Q1 Results
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 6:58AM CDT
Share price of Exactech Inc (EXAC) reached a new 52-week high of $25.86 on Jun 14.
IRMD: 17.31 (-0.30), MASI: 59.90 (+0.47), EXAC: 27.90 (+0.10), CRY: 16.23 (+0.39)

Exactech Has Returned 26.6% Since SmarTrend Recommendation (EXAC)
Comtex SmarTrend(R) - Fri Jun 10, 1:24PM CDT
SmarTrend identified an Uptrend for Exactech (NASDAQ:EXAC) on April 1st, 2016 at $20.01. In approximately 2 months, Exactech has returned 26.59% as of today's recent price of $25.33.
EXAC: 27.90 (+0.10)

DENTSPLY (XRAY) Scales a 52-Week High on Strong Q1 Results
Zacks Equity Research - Zacks Investment Research - Fri Jun 10, 6:02AM CDT
Shares of DENTSPLY International Inc. (XRAY) rallied to a new 52-week high of $64.59 on Jun 9.
IRMD: 17.31 (-0.30), MASI: 59.90 (+0.47), EXAC: 27.90 (+0.10), XRAY: 61.70 (+0.05)

TrovaGene: Trovera Liquid Biopsy Urine Test Results Positive (Revised)
Zacks Equity Research - Zacks Investment Research - Fri Jun 10, 3:37AM CDT
TrovaGene Inc. (TROV) recently presented clinical results demonstrating the effectiveness of its Trovera non-invasive test in detecting EGFR T790M mutations.
IRMD: 17.31 (-0.30), MASI: 59.90 (+0.47), TROV: 4.96 (unch), EXAC: 27.90 (+0.10)

Exactech and University of Florida Expand Partnership, Promote Health Education with Naming of "Exactech Arena" at the Stephen C. O'Connell Center
BusinessWire - Thu Jun 09, 3:59PM CDT
Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic materials for extremities, knee, hip and spine, announced today an expansion of its long-standing partnership with the University of Florida (UF) through naming of Exactech Arena at the newly remodeled Stephen C. O'Connell Center, a sports and entertainment complex on the university's campus.
EXAC: 27.90 (+0.10)

TrovaGene: Trovera Liquid Biopsy Urine Test Results Positive
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 8:39AM CDT
TrovaGene Inc. (TROV) recently presented clinical results demonstrating the effectiveness of its Trovera non-invasive test in detecting EGFR T790M mutations in the urine of patients with non-small cell lung cancer (NSCLC).
IRMD: 17.31 (-0.30), MASI: 59.90 (+0.47), TROV: 4.96 (unch), EXAC: 27.90 (+0.10)

Natus Medical Expands Share Repurchase Program by $20M
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 5:54AM CDT
Natus Medical Inc. (BABY) recently announced an expansion of its share repurchase program, which authorizes it to buy back additional shares worth $20 million by Jun 1, 2017.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), EXAC: 27.90 (+0.10), CRY: 16.23 (+0.39)

Exactech Up 24.9% Since SmarTrend Uptrend Call (EXAC)
Comtex SmarTrend(R) - Fri Jun 03, 1:04AM CDT
SmarTrend identified an Uptrend for Exactech (NASDAQ:EXAC) on April 1st, 2016 at $20.01. In approximately 2 months, Exactech has returned 24.89% as of today's recent price of $24.99.
EXAC: 27.90 (+0.10)

Inogen (INGN) Introduces Next-Gen Inogen One G4 POC
Zacks Equity Research - Zacks Investment Research - Wed Jun 01, 7:15AM CDT
Inogen Inc (INGN) recently launched a next-generation portable oxygen concentrator (POC) -- Inogen One G4.
MASI: 59.90 (+0.47), INGN: 58.11 (+0.16), EXAC: 27.90 (+0.10), CRY: 16.23 (+0.39)

Shares of EXAC Up 21.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu May 26, 1:34PM CDT
SmarTrend identified an Uptrend for Exactech (NASDAQ:EXAC) on April 1st, 2016 at $20.01. In approximately 2 months, Exactech has returned 21.24% as of today's recent price of $24.26.
EXAC: 27.90 (+0.10)

Cynosure (CYNO) Up on FDA Approval for New 1064nm LDS
Zacks Equity Research - Zacks Investment Research - Wed May 25, 7:44AM CDT
Cynosure Inc. (CYNO) recently announced the receipt of FDA approval for marketing a new Laser Delivery System (LDS) for PicoSure.
IRMD: 17.31 (-0.30), MASI: 59.90 (+0.47), CYNO: 51.59 (-0.36), EXAC: 27.90 (+0.10)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PharmaBlock Forum: Strategic CMC Moves Crucial for Biotech

CMC Strategies: The Unsung Hero in Biotech Development Ah, the world of biotech, where one day you're a hero in the lab, and the next you're scrambling to make sense of chemistry, manufacturing, and controls (CMC). It's high time folks started realizing that CMC isn't just procedural drudgery—it's the backbone of making a promising drug go global. That's what the...

ASMAX Unleashes Next-Level Motorcycle Comms at EICMA

Transforming the Motorcycle Communication Landscape Motorcycling ain't just about the roaring engines and the rubber on the road. In the world of helmets and handlebars, some bright minds are weaving tech magic at the EICMA 2026 in Milan. ASMAX has rolled out its shiny new RoamX intercom gadget, leaving folks buzzing at Hall 6. What RoamX Brings to the Table This ain't...

Family-Run Pet Retailer Debuts in Alamo Ranch

Pet Supplies Plus Opens Its Doors in Alamo Ranch A fresh wave of pet-centered enthusiasm hit Alamo Ranch as Ray and Naz, proud local entrepreneurs, unveiled their new Pet Supplies Plus store on October 23. This isn't just any run-of-the-mill pet supply shop; it's a reflection of their personal journey as devoted pet parents. With a blend of grit and community spirit,...

Tigo Energy Faces Class Action: Investor Deadline Looms

Unpacking Tigo's Rollercoaster: Lawsuit & Market Reaction They sometimes say, "When it rains, it pours." For Tigo Energy, it’s been more a downpour than a drizzle. Here we are, chasing down what's going on with Tigo Energy (NASDAQ:TYGO), fresh off the heels of a class action fuss that's grabbed every investor's attention. If you've got a stake, or even a passing...

Valve Tool Innovation Streamlines Hydraulic Maintenance

A New Gadget Promises Big Savings in Time and Effort Ever wrestled with a hydraulic hose and felt like you were arm wrestling a gorilla? Well, it looks like there's a new gadget on the scene that might save you from that struggle. Straight from Menomonie, Wisconsin, we’ve got a slick new tool hitting the market called THE VALVE TOOL. The idea is simple but effective:...

SpaceMap Tackles Space Traffic With AI Innovation

SpaceMap Takes Aim at the Crowded Space Above You ever look up and wonder what's hurtling above our noggins? More satellites than you can shake a stick at, that's what. And don't even start me on the debris floating around. This ain't just rocket science anymore; it's a crowded dance floor, and someone's gotta manage it. Enter SpaceMap, a plucky South Korean startup that...

Laboratoires Pierre Fabre and XtalPi Unite for AI-Driven Drug Hunt

An Unexpected Turn in the Drug Discovery Arena It's not every day that you see a historic French pharma powerhouse and a cutting-edge Chinese tech firm join forces. On one side, we've got Laboratoires Pierre Fabre, steeped in the history and nitty-gritty of clinical drug development. On the other, we’ve got XtalPi Holdings Limited (2228.HK), bringing their high-tech AI...

PrimeFlight Welcomes CEO Amath Fall for Global Growth

A New Era Begins at PrimeFlight On a cloudy November morning in Sugar Land, Texas, some interesting news broke out of PrimeFlight Aviation Services. They've made what seems like a pivotal move by appointing Amath Fall as their new Chief Executive Officer, effective immediately. As PrimeFlight continues to elbow its way into new market territory, having someone like Fall...

Painter Capri: Comfort Revolution or Just Hype?

A New Hope for Painters' Comfort? Alright, here we go. Some folks out there in the land of ladders and rollers have had it with wearing uncomfortable, stifling work gear every day. Enter the PAINTER CAPRI. Designed by an inventive spirit from Homer Glen, Illinois, these pants aim to be both breathable and functionally sound—for painters, electricians, and other gritty...

Understanding Hired & Non-Owned Auto Insurance Basics

The Overlooked Gap in Auto Coverage Bet you didn't see this one coming: businesses often overestimate their auto insurance coverage, assuming their commercial policies cover all the bases. When employees drive personal vehicles for work purposes or when businesses borrow rides temporarily, these assumptions leave a gaping hole bigger than a sinkhole in a Florida street....